Cara Therapeutics (CARA): Stock Price

Cara Therapeutics Inc - graphic logo of issuer CARA

This daily price chart for Cara Therapeutics, Inc. (CARA) reflects the current market trend, with the key indicator standing at 1.02. The business relies on a fabless model, outsourcing chemical synthesis and testing to third-party contractors. The implementation of robotic systems in receptor research accelerates development without the need for additional hiring. Furthermore, Cara Therapeutics, Inc. (CARA) effectively delegates primary tests to established CRO networks to ensure the rapid creation of drugs.

Price Performance Chart: Cara Therapeutics Inc (CARA) for 07/04/2022 - 11/18/2026

Cara Therapeutics, Inc (CARA) - metric breakdowns and financial figures

Analysis of all company metrics:caratherapeutics.com CARA
Signature product of Cara Therapeutics Inc.

The uniqueness of the mechanisms of action of Cara Therapeutics, Inc. (CARA) drugs in the competition for the neurological disorders market directly determines the volatility of the stock price trend. This indicator reflects the market capitalization of a single share of the business, capturing the real-time revaluation of assets by investors following the publication of financial reports. An analysis of the quotes allows for an assessment of the scale of the market reaction to the issuer's competitive successes, determining the current investment attractiveness of the company.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|pasitheaclinics.com (KTTA) - Market Chart|Price Chart Cortigent Inc (CRGT)|Avenue Therapeutics, Inc. - Share Price|Price Chart Brainstorm Cell Therapeutics, Inc. BCLI|Market Chart Chromocell Therapeutics Corporation (CHRO)|Eliem - Stock Price|Market Chart intracellulartherapies.com ITCI|Longboard Pharmaceuticals Inc (LBPH) - Price Chart|Marinus Pharmaceuticals Inc - Price Performance Chart|Price Chart NKGen|Price Chart NRBO|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel